Palforzia
*Company:
Aimmune Therapeutics Ireland LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 11 October 2022
File name
Commercial_PIL_IRL_Sep_2022.pdf
Reasons for updating
- Change to section 6 - date of revision
Updated on 07 October 2022
File name
Commercial_SmPC_IRL_Aug_2022_.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 07 October 2022
File name
Commercial_PIL_IRL_Jul_2021_V2.0.pdf
Reasons for updating
- New PIL for new product